Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Director Kimberly H. Johnson acquired 10 shares of Eli Lilly stock through a deferral plan, with settlement occurring after her service ends.

Summary

• Kimberly H. Johnson, a director at Eli Lilly & Co, acquired 10 shares of common stock on August 19, 2024.
• The shares were acquired at a price of $921.81 per share.
• These shares were obtained through the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• The shares will be settled in common stock after Ms. Johnson's separation from service.
• The transaction was reported on August 20, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally neutral to positive. The director's participation in the deferral plan suggests confidence in the company's future.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to insider transactions, which is common for publicly traded companies. It reflects a director's participation in a company's compensation plan.

Comparison to Industry Standards

• Director stock acquisitions are a common practice in publicly traded companies, often as part of compensation packages.
• Deferral plans are also a standard method for directors to receive equity compensation, aligning their interests with long-term shareholder value.
• The price of $921.81 per share is consistent with the market price of LLY stock at the time of the transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.

Key Dates

Keywords

insider trading, stock acquisition, director, share purchase, deferral plan, LLY, Eli Lilly